A novel pegylated bispecific antibody-drug conjugate (P-BsADC) targeting Her2+cancers with improved efficacy and therapeutic window

被引：0
|
作者：
Wen, Yu
Yin, Shuqiang
Lyu, Weidong
Lei, Yang
Zhuo, Qiudong
Wu, Zibin
Sun, Bin
Tan, Shuangyu
Jiang, Lidong
Zhang, Teng
Gao, Bo
Xu, Rui
Li, Yong
Zheng, Liling
Liu, Shumin
Wu, David
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-4000
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4000
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Combined inhibition of PARP and ATR synergistically potentiates the antitumor activity of HER2-targeting antibody-drug conjugate in HER2-positive cancers
    Li, Yongpeng
    Li, Lin
    Fu, Haoyu
    Yao, Qing
    Wang, Lei
    Lou, Liguang
    AMERICAN JOURNAL OF CANCER RESEARCH, 2023, 13 (01): : 161 - +
  • [22] Novel CDH17-targeting antibody-drug conjugate exhibits anti-tumor efficacy in preclinical models of gastrointestinal cancers
    Wong, Po Yee
    He, Lin
    Chow, Kronos
    Wong, Kwan Wa
    O, Chui Yee
    Wong, Dennis
    Luk, John Moon
    Lo, Pui-Chi
    Wong, Kwong Fai
    CANCER RESEARCH, 2024, 84 (06)
  • [23] An Innovative Site-Specific Anti-HER2 Antibody-Drug Conjugate with High Homogeneity and Improved Therapeutic Index
    Hui, Xiwu
    Yuan, Can
    Cao, Weirong
    Ge, Wenli
    Zhang, Di
    Dan, Mo
    Zhao, Qian
    Liu, Boning
    Yao, Bing
    ONCOTARGETS AND THERAPY, 2022, 15 : 331 - 343
  • [24] Targeting Vesicular LGALS3BP by an Antibody-Drug Conjugate as Novel Therapeutic Strategy for Neuroblastoma
    Capone, Emily
    Lamolinara, Alessia
    Pastorino, Fabio
    Gentile, Roberta
    Ponziani, Sara
    Di Vittorio, Giulia
    D'Agostino, Daniela
    Bibbo, Sandra
    Rossi, Cosmo
    Piccolo, Enza
    Iacobelli, Valentina
    Lattanzio, Rossano
    Panella, Valeria
    Sallese, Michele
    De Laurenzi, Vincenzo
    Giansanti, Francesco
    Sala, Arturo
    Iezzi, Manuela
    Ponzoni, Mirco
    Ippoliti, Rodolfo
    Iacobelli, Stefano
    Sala, Gianluca
    CANCERS, 2020, 12 (10) : 1 - 18
  • [25] A bispecific antibody-drug conjugate targeting pCAD and CDH17 has antitumor activity and improved tumor-specificity
    Synan, Alyssa
    Wu, Nila C.
    Velazquez, Roberto
    Gesner, Thomas
    Logel, Claude
    Mueller, Kathrin
    Green, Andrew
    Barzaghi-Rinaudo, Patrizia
    Simmons, Quincey
    Mercan, Samuele
    Shi, Xingyi
    Li, Xun
    Sagar, Vivek
    Korn, Joshua
    Mclaughlin, Margaret
    Tschantz, William R.
    Hainzl, Dominik
    Malamas, Anthony
    Huber, Thomas
    Cebe, Regis
    Xie, Kathleen T.
    D'Alessio, Joseph A.
    MABS, 2025, 17 (01)
  • [26] YH013, a novel EGFR x MET bispecific antibody-drug conjugate, exhibits potent antitumor efficacy
    Han, Yanfei
    Shang, Chengzhang
    Li, Zhuon
    Han, Zhenyan
    Li, Jun
    Cui, Zixu
    An, Gao
    Hao, Wanjun
    Liu, Yujie
    Li, Hao
    Liu, Baihong
    Zhang, Ellen
    Lin, Qingcong
    Yang, Yi
    Shen, Yuelei
    CANCER RESEARCH, 2023, 83 (07)
  • [27] Trastuzumab emtansine: a novel antibody-drug conjugate for HER2-positive breast cancer
    Burris, Howard A., III
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2011, 11 (06) : 807 - 819
  • [28] Trastuzumab Emtansine: A Novel Antibody-Drug Conjugate for HER2-Positive Breast Cancer
    Krop, Ian
    Winer, Eric P.
    CLINICAL CANCER RESEARCH, 2014, 20 (01) : 15 - 20
  • [29] Therapeutic efficacy of antibody-drug conjugates targeting GD2-positive tumors
    Kalinovsky, Daniel, V
    Kibardin, Alexey, V
    Kholodenko, Irina, V
    Svirshchevskaya, Elena, V
    Doronin, Igor I.
    Konovalova, Mariya, V
    Grechikhina, Maria, V
    Rozov, Fedor N.
    Larin, Sergey S.
    Deyev, Sergey M.
    Kholodenko, Roman, V
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (06)
  • [30] Targeting the activated allosteric conformation of the endothelin receptor B in melanoma with an antibody-drug conjugate: mechanisms and therapeutic efficacy
    Amaury Herbet
    Marie Hautière
    Frédéric Jean-Alphonse
    Delphine Vivier
    Christophe Leboeuf
    Narciso Costa
    Aloïse Mabondzo
    Guilhem Bousquet
    Franck Denat
    Eric Reiter
    Didier Boquet
    BJC Reports, 3 (1):
12345